Alto Neuroscience appoints Michael Hanley as Chief Operating Officer effective May 20, 2024

Alto Neuroscience, Inc.

Hanley receives $470,000 base salary, 40% annual performance bonus target, and option for 188,000 shares.
Option vests 25% on 1-year anniversary, then monthly over 4 years, subject to continuous service.
Severance: 9 months salary plus COBRA on non-cause termination; 12 months salary, bonus, and full equity acceleration upon change in control termination.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Michael Hanley

Chief Operating Officer

ANRO · Alto Neuroscience, Inc.

Effective: 2024-05-20
Filed: May 21, 2024, 7:59 PM ET

On May 21, 2024, Alto Neuroscience, Inc. (the “Company”) announced that the Board of Directors of the Company (the “Board”) appointed Michael Hanley as the Chief Operating Officer of the Company, effective as of May 20, 2024

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.99

Michael Hanley was appointed as Chief Operating Officer at Alto Neuroscience, Inc..

Action: appointed
Role: Chief Operating Officer

Exact text from the filing

On May 21, 2024, Alto Neuroscience, Inc. (the “Company”) announced that the Board of Directors of the Company (the “Board”) appointed Michael Hanley as the Chief Operating Officer of the Company, effective as of May 20, 2024

View on SEC.gov

Alto Neuroscience, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-143369

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.